Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03403049Phase 1Completed
Phase 1, open-label, single-arm trial in pancreatic cancer (PC), sponsored by Montefiore Medical Center. Primary endpoint: Dose-limiting toxicity at 90 days. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03403049.